Khaitan & Co advised Torrent Pharmaceuticals Limited in relation to acquisition financing facility of INR 2800 crores raised through a combination of loan and non-convertible debentures for the purpose of financing the acquisition of branded businesses of Unichem Laboratories Limited. Kumar Saurabh Singh (Partner), Soumava Chatterjee (Principal Associate) and Oindrila Bhowmik (Associate). Torrent Pharmaceuticals Limited, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Khaitan & Co, as the sole legal counsel to Torrent Pharmaceuticals Limited in relation to the transaction.